UPDATE : Monday, December 17, 2018
상단여백
‘JAK inhibitors to change quality of life for people with polycythemia vera’
“Janus kinase (JAK) inhibitors, a type of medication that suppresses the ac...
by Park Gi-taek  |  2018-11-09 13:32
라인
Sanofi releases 2 clinical trial results for antidiabetic treatment
Sanofi Aventis Korea has unveiled two phase 3 clinical trial results for So...
by Lee Han-soo  |  2018-11-08 17:13
라인
Ildong Hyaltech to export HA filler to Brazil
Ildong Hyaltech, a subsidiary of Ildong Pharmaceutical, said Thursday that ...
by Lee Han-soo  |  2018-11-08 15:16
라인
Dong-A ST’s athlete’s foot treatment exceeds annual sales of ₩10 billion
Dong-A ST said Thursday that Jublia, a toenail fungal treatment, has surpas...
by Lee Han-soo  |  2018-11-08 15:16
라인
Well Marker Bio raises ₩28 billion for anticancer drug development
Anticancer treatment developer Well Marker Bio said it has completed the so...
by Lee Hye-seon  |  2018-11-08 15:10
라인
Hanmi rolls out new generic drug to beat Pfizer’s anti-nicotine therapy
After failing to outrival Pfizer in the anti-smoking treatment market with ...
by So Jae-hyeon  |  2018-11-07 16:07
라인
Ministry OKs P1 clinical trials for JW’s atopy treatment
JW Pharmaceutical said Wednesday that it has received approval from the Min...
by Lee Han-soo  |  2018-11-07 16:06
라인
CJ HealthCare aims to add indication for Helicobacter eradication
CJ HealthCare is seeking to add an indication for the eradication of Helico...
by Lee Hye-seon  |  2018-11-07 14:58
라인
Huons completes P3 clinical trials for Hutox
Huons Global said Tuesday that it has completed domestic phase 3 clinical t...
by Lee Han-soo  |  2018-11-07 12:26
라인
Sanofi confirms continuous therapeutic benefits for relapsing-remitting multiple sclerosis treatment
Sanofi Genzyme Korea said Tuesday that it has presented a new study on Lemt...
by Lee Han-soo  |  2018-11-06 11:09
라인
LG Chem to work on bilayer tablet for diabetes, dyslipidemia
LG Chem said it would start developing bilayer tablets of Zemiro (gemiglipt...
by Lee Hye-seon  |  2018-11-06 11:06
라인
Celltrion wins suit against Roche to invalidate Herceptin patent in Japan
Korea’s biosimilar company Celltrion is likely to accelerate its move to ex...
by So Jae-hyeon  |  2018-11-05 15:26
라인
GC starts developing shingles vaccine in US
GC said Monday that its U.S. subsidiary Cuervo has received U.S. Food and D...
by Lee Han-soo  |  2018-11-05 13:31
라인
Lilly Korea’s rheumatoid arthritis treatment wins insurance coverage
Lilly Korea said Thursday that it has gained reimbursement for its rheumato...
by Lee Han-soo  |  2018-11-02 17:52
라인
Why did pharmaceuticals release hair loss drugs in tablet form?
Why have Korean pharmaceutical companies released hair loss treatments in t...
by So Jae-hyeon  |  2018-11-02 12:43
라인
Genexine wins FDA nod for clinical trials of HyLeukin-7
Genexine and NeoImmuneTech have received approval from the U.S. Food and Dr...
by Lee Han-soo  |  2018-11-01 11:03
라인
Acer submits new drug application for rare disease to FDA
Acer Therapeutics, a NASDAQ-listed pharmaceutical firm in which Bukwang Pha...
by Park Gi-taek  |  2018-10-31 15:55
라인
Korea’s drug exports to US inch down this year
Korea’s exports of pharmaceutical products to the U.S. slightly went down i...
by Nam Doo-hyun  |  2018-10-31 12:22
라인
Dong-A ST’s Q-3 sales slid to ₩140.8 billion
Dong-A ST said Tuesday that it recorded sales of 140.8 billion won ($123.5 ...
by Lee Han-soo  |  2018-10-31 11:46
라인
Hanmi’s leukemia drug candidate wins FDA’s orphan drug status
Hanmi Pharmaceutical said Wednesday that its HM43239, a drug candidate in t...
by Lee Han-soo  |  2018-10-31 11:45
여백
여백
여백
Back to Top